Evolus, Inc. EOLS
7.56 USD +0.18 (+2.51%)
Nov 4, 2026, 2:30 PM EST
7.33 Day range 7.65
3.86 52-week range 9.31
- YTD
- +13.61%
- 1 year
- +17.86%
Analyst view
Consensus: buy
Buy
Price target (mean) 23.43 +210.1% upside
Now 7.56
- Target (low)
- 20.00
- Target (mean)
- 23.43
- Target (high)
- 27.00
Ratings (0m) 7 7 buy · 0 hold · 0 sell
- Strong buy4
- Buy3
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 7
- 2 months ago 7
- 3 months ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.001 | -0.02 – 0.017 | -0.1449 | +99.3% | 77.23M | +26.6% | 3 |
| Next quarter | -0.012 | -0.012 – -0.012 | -0.10973 | +89.1% | 75.38M | +27.1% | 1 |
| Current year | -0.282 | -0.30 – -0.26 | -0.7198 | +60.8% | 264.21M | +30.7% | 4 |
| Next year | 0.048 | -0.208 – 0.41 | -0.282 | +117.0% | 347.37M | +31.5% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 7, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 3, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 16, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Sep 13, 2024 | Barclays | Maintained | Overweight | Overweight |
| Sep 13, 2024 | Needham | Reiterated | Buy | Buy |
| Sep 9, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Aug 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 1, 2024 | Needham | Reiterated | Buy | Buy |
| Jun 20, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| May 21, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 8, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 8, 2024 | Needham | Reiterated | Buy | Buy |
| Apr 10, 2024 | Needham | Reiterated | Buy | Buy |
| Mar 8, 2024 | Stifel | Reiterated | Buy | Buy |
| Mar 8, 2024 | Needham | Reiterated | Buy | Buy |
| Mar 8, 2024 | Mizuho | Maintained | Buy | Buy |
| Mar 8, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 29, 2024 | Barclays | Upgrade | Equal-Weight | Overweight |
| Jan 17, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Dec 20, 2023 | Needham | Reiterated | Buy | Buy |
| Aug 3, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 3, 2023 | Needham | Reiterated | Buy | Buy |
| Jul 28, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 7, 2023 | Mizuho | Maintained | Buy | Buy |
| May 26, 2023 | Truist Securities | Maintained | Buy | Buy |
| May 10, 2023 | Needham | Maintained | Buy | Buy |
| May 10, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Mar 9, 2023 | Needham | Reiterated | — | Buy |